Adaptive Biotechnologies Corp. (ADPT)
27.98
+1.15
(+4.29%)
USD |
NASDAQ |
Nov 06, 16:00
27.43
-0.55
(-1.97%)
After-Hours: 20:00
Adaptive Biotechnologies Total Long Term Debt (Quarterly) : 399.83M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 399.83M |
| June 30, 2026 | 401.68M |
| March 31, 2026 | 199.67M |
| December 31, 2025 | 201.44M |
| September 30, 2025 | 204.20M |
| June 30, 2025 | 207.98M |
| March 31, 2025 | 210.00M |
| December 31, 2024 | 212.43M |
| September 30, 2024 | 214.50M |
| June 30, 2024 | 216.45M |
| March 31, 2024 | 218.44M |
| December 31, 2023 | 220.05M |
| September 30, 2023 | 221.75M |
| June 30, 2023 | 222.34M |
| March 31, 2023 | 223.50M |
| December 31, 2022 | 224.13M |
| September 30, 2022 | 225.08M |
| Date | Value |
|---|---|
| June 30, 2022 | 102.73M |
| March 31, 2022 | 104.98M |
| December 31, 2021 | 106.68M |
| September 30, 2021 | 108.04M |
| June 30, 2021 | 103.77M |
| March 31, 2021 | 95.25M |
| December 31, 2020 | 104.33M |
| September 30, 2020 | 42.37M |
| June 30, 2020 | 42.50M |
| March 31, 2020 | 36.54M |
| December 31, 2019 | 36.61M |
| September 30, 2019 | 23.45M |
| June 30, 2019 | 561.93M |
| March 31, 2019 | 561.56M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Champions Oncology, Inc. | 10.34M |
| Medpace Holdings, Inc. | 146.04M |
| Avantor, Inc. | 3.684B |
| Personalis, Inc. | 30.21M |
| 10X Genomics, Inc. | 63.85M |